Bolt Biotherapeutics Inc.
BOLT | NASDAQ
$3.59
$0 (0.00%)
Sep 22, 2026, 10:46 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 5K | 26K | 2.5M | 2.17M | 1.8M | 1.22M | n/a | 1.14M | 1.28M | 5.27M | 2.09M | 2.53M | 1.43M | 1.83M | 1.41M | 2.11M | 1.39M | 813K | 508K | 752K | n/a | n/a |
Cost of Revenue | n/a | 203K | n/a | n/a | n/a | n/a | 426K | 13.79M | 15.43M | 458K | 16.32M | 14.95M | 15.64M | 14.63M | 16.85M | 18.97M | 18.92M | 18.39M | 22.48M | 19.34M | 19.71M | 14.13M |
Gross Profit | 5K | -177K | 2.5M | 2.17M | 1.8M | 1.22M | -426K | -12.64M | -14.16M | 4.82M | -14.23M | -12.42M | -14.21M | -12.8M | -15.43M | -16.86M | -17.53M | -17.57M | -21.98M | -18.59M | -19.71M | -14.13M |
Operating Income | -8.37M | -7.6M | -5.61M | -7.7M | -9.21M | -12.12M | -15.67M | -16.44M | -22.6M | -17.09M | -19.77M | -18.18M | -19.83M | -18.42M | -21.04M | -22.35M | -23.06M | -23.88M | -27.08M | -23.53M | -23.76M | -18.43M |
Interest Income | 178K | 276K | 367K | 477K | 599K | 1.05M | 980K | 1.27M | 1.4M | 1.61M | 1.86M | 1.93M | 1.78M | 1.44M | 1.04M | 587K | 395K | 198K | n/a | 131K | 176K | 56K |
Pretax Income | -7.72M | -7.24M | -6.63M | -7.14M | -8.56M | -11.04M | -15.94M | -15.18M | -21.2M | -10.81M | -17.9M | -16.26M | -18.06M | -16.98M | -20M | -21.76M | -22.66M | -23.68M | -27.16M | -23.4M | -23.59M | -24.45M |
Net Income | -7.72M | -7.24M | -6.63M | -7.14M | -8.56M | -11.04M | -15.94M | -15.18M | -21.2M | -10.81M | -17.9M | -16.26M | -18.06M | -16.98M | -20M | -21.76M | -22.66M | -23.68M | -27.16M | -23.4M | -23.59M | -24.45M |
Selling & General & Admin | 2.42M | 2.8M | 3.12M | 3.34M | 3.52M | 3.83M | 3.95M | 3.8M | 4.87M | 5.84M | 5.53M | 5.76M | 5.62M | 5.62M | 5.61M | 5.49M | 5.53M | 6.3M | 5.1M | 4.94M | 4.05M | 4.3M |
Research & Development | 5.15M | 4.63M | 4.99M | 6.54M | 7.5M | 9.51M | 11.3M | 13.79M | 15.43M | 16.07M | 16.32M | 14.95M | 15.64M | 14.63M | 16.85M | 18.97M | 18.92M | 18.39M | 22.48M | 19.34M | 19.71M | 14.13M |
Other Expenses | 808K | n/a | n/a | n/a | n/a | n/a | n/a | -13.79M | -11.87M | n/a | -16.32M | -14.95M | -15.64M | -14.63M | -16.85M | -18.97M | -18.92M | -18.39M | -22.48M | -19.34M | -19.71M | -14.13M |
Operating Expenses | 8.38M | 7.42M | 8.11M | 9.87M | 11.01M | 13.34M | 15.24M | 3.8M | 8.44M | 21.91M | 5.53M | 5.76M | 5.62M | 5.62M | 5.61M | 5.49M | 5.53M | 6.3M | 5.1M | 4.94M | 4.05M | 4.3M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 82K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 8.38M | 7.63M | 8.11M | 9.87M | 11.01M | 13.34M | 15.67M | 17.58M | 23.87M | 22.37M | 21.86M | 20.71M | 21.27M | 20.24M | 22.45M | 24.46M | 24.45M | 24.69M | 27.58M | 24.28M | 23.76M | 18.43M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.69M | 1.87M | 1.87M | 1.92M | 1.92M | 1.92M | 1.91M | 1.91M | 1.91M | 1.9M | 1.9M | 1.89M | 1.89M | 1.88M | 1.88M | 1.87M | 1.86M | 1.86M | 1.86M | 1.86M | 1.83M | 1.71M |
Shares Outstanding (Diluted) | 1.69M | 1.87M | 1.87M | 1.92M | 1.92M | 1.92M | 1.91M | 1.91M | 1.91M | 1.9M | 1.9M | 1.89M | 1.89M | 1.88M | 1.88M | 1.87M | 1.86M | 1.86M | 1.86M | 1.86M | 1.83M | 1.71M |
EPS (Basic) | -4.57 | -3.87 | -3.84 | -3.72 | -4.46 | -0.29 | -0.42 | -0.40 | -0.56 | -0.28 | -0.47 | -0.43 | -0.48 | -0.41 | -0.50 | -0.58 | -0.60 | -0.63 | -0.73 | -0.63 | -0.64 | -0.71 |
EPS (Diluted) | -4.57 | -3.87 | -3.84 | -3.72 | -4.46 | -0.29 | -0.42 | -0.40 | -0.56 | -0.28 | -0.47 | -0.43 | -0.48 | -0.41 | -0.50 | -0.58 | -0.60 | -0.63 | -0.73 | -0.63 | -0.64 | -0.71 |
EBITDA | -7.55M | -7.04M | -6.38M | -6.85M | -8.21M | -10.64M | -15.51M | -14.74M | -18.58M | -10.35M | -17.44M | -15.8M | -17.6M | -16.51M | -19.54M | -21.32M | -22.26M | -23.32M | -26.71M | -23.09M | -23.33M | -18.15M |
EBIT | -7.72M | -7.24M | -6.63M | -7.14M | -8.56M | -11.04M | -15.94M | -15.18M | -19.03M | -10.81M | -17.9M | -16.26M | -18.06M | -16.98M | -20M | -21.76M | -22.66M | -23.68M | -27.08M | -23.4M | -23.59M | -18.43M |
Depreciation & Amortization | 171K | 203K | 255K | 290K | 347K | 399K | 426K | 440K | 457K | 458K | 467K | 462K | 458K | 467K | 462K | 439K | 408K | 357K | 361K | 304K | 256K | 272K |
Add to Watchlist
Select watchlists to add or remove BOLT